NFKB1 and hepatocellular carcinoma: Ting Dai et al. found that GOLPH3 is a prognostic and/or potential therapeutic biomarker for hepatocellular carcinoma cell (HCC) patients, playing an important role in the activation of the NF-κB pathway during HCC progression (Dai et al., 2015).